"Study of oral clofarabine plus low-dose cytarabine in previously treated AML and high-risk MDS patients at least age 60." by K. M. Smith

Selected Works of John M. Pagel, MD, PhD

Article

Study of oral clofarabine plus low-dose cytarabine in previously treated AML and high-risk MDS patients at least age 60.

Journal of Clinical Oncology (2011)

K. M. Smith
E. Estey, Fred Hutchinson Cancer Research Center
J. M. Pagel, University of Washington

Link

Disciplines

Physical Therapy and
Medicine and Health Sciences

Publication Date

May 20, 2011

DOI

10.1200/jco.2011.29.15_suppl.6549

Citation Information

K. M. Smith, E. Estey and J. M. Pagel. "Study of oral clofarabine plus low-dose cytarabine in previously treated AML and high-risk MDS patients at least age 60." Journal of Clinical Oncology Vol. 29 (2011) p. 6549 - 6549
Available at: http://works.bepress.com/john-pagel/177/